Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
17.6M
-
Shares change
-
-532K
-
Total reported value, excl. options
-
$429M
-
Value change
-
-$15.1M
-
Number of buys
-
42
-
Number of sells
-
-17
-
Price
-
$24.40
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2016
71 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q2 2016.
Editas Medicine, Inc. - Common Stock (EDIT) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.6M shares
of 82.8M outstanding shares and own 21.3% of the company stock.
Largest 10 shareholders include FMR LLC (5.45M shares), Polaris Venture Management Co. VI, L.L.C. (4.66M shares), Viking Global Investors LP (1.71M shares), DEERFIELD MANAGEMENT CO (1.71M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.41M shares), VANGUARD GROUP INC (533K shares), MORGAN STANLEY (298K shares), Capital World Investors (295K shares), Alphabet Inc. (256K shares), and JENNISON ASSOCIATES LLC (171K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.